Reaction
Gastrointestinal Bacterial Overgrowth reporting signals
As of the last recalculation, Gastrointestinal Bacterial Overgrowth appears in 601 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is RIFAXIMIN (PRR 232.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rifaximin | 114 | 232.4 | 233.6 |
| Teduglutide | 27 | 72.6 | 72.8 |
| Olmesartan Medoxomil | 28 | 28.2 | 28.3 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 4 | 16.3 | 16.4 |
| Vedolizumab | 38 | 16.2 | 16.2 |
| Palivizumab | 3 | 6.8 | 6.8 |
| Copper | 4 | 3.2 | 3.2 |